ascopubs.org

Randomized phase III study of nedaplatin (N) plus docetaxel (D) versus cisplatin (C) plus D for advanced or relapsed squamous cell carcinoma of the lung (SqLC): WJOG5208L.

Cabozantinib (C), erlotinib (E) or the combination (E+C) as second- or third-line therapy in patients with EGFR wild-type (wt) non-small cell lung cancer (NSCLC): A randomized phase 2 trial of the ...
ascopubs.org

ERCC1 expression in tumor tissue as biomarker of outcomes of oral vinorelbine-cisplatin (oVP) combination in metastatic squamous cell lung cancer (SqLC): A prospective study ...

Use of FDA-approved vs. lab-developed tests in advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a full text ...
D Magazine

Edgemere Owner SQLC Names A New Chief Executive

Addison-based Senior Quality Lifestyles Corp., which owns the Edgemere life-care community in Dallas and The Stayton at Museum Way in Fort Worth, has announced changes in its top ranks. The board of ...